Area of research
Molecular Biology · Oncology
Research interest
Research interests include Protein Kinase Regulation and GTPase Signaling, Pancreatic and Hepatic Oncology Research, CRISPR and Genetic Engineering, and Protein Degradation and Inhibitors.
STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer
Functional and biological heterogeneity of KRAS <sup>Q61</sup> mutations
Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies
RAS isoforms and mutations in cancer at a glance
Copper is required for oncogenic BRAF signalling and tumorigenesis
Glutathiolated Ras: Characterization and implications for Ras activation